Based on these findings it is very well possible that several underlying disease mechanisms and disease-driving pathways are involved to varying degrees in different MLL-r leukemia subtypes (ALL vs AML), for different MLL translocations and even breakpoint localizations within the gene [42, 43]. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.